Citius Pharmaceuticals, Inc.
CTXR
$0.85
$0.000.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.25M | 6.09M | 26.40K | 1.10M | 3.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 22.29M | 17.21M | 15.34M | 14.38M | 8.27M |
| Prepaid Expenses | 1.40M | 1.31M | 3.01M | 2.85M | 2.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.93M | 24.61M | 18.37M | 18.33M | 14.22M |
|
|
|||||
| Total Current Assets | 27.93M | 24.61M | 18.37M | 18.33M | 14.22M |
| Net Property, Plant & Equipment | 818.70K | 880.70K | 922.10K | 191.40K | 246.20K |
| Long-term Investments | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Goodwill | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Total Other Intangibles | 92.80M | 92.80M | 92.80M | 92.80M | 92.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.10K | 38.10K | 38.10K | 38.10K | 38.10K |
| Total Assets | 130.94M | 127.68M | 121.48M | 120.70M | 116.65M |
|
|
|||||
| Total Accounts Payable | 13.69M | 10.09M | 9.37M | 7.36M | 4.93M |
| Total Accrued Expenses | 7.48M | 12.23M | 11.96M | 8.84M | 2.25M |
| Short-term Debt | 1.00M | 1.00M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 88.30K | 114.70K | 145.10K | 204.60K | 241.50K |
| Total Finance Division Other Current Liabilities | 22.65M | 28.40M | 28.40M | 28.40M | 28.40M |
| Total Other Current Liabilities | 22.65M | 28.40M | 28.40M | 28.40M | 28.40M |
| Total Current Liabilities | 44.91M | 51.84M | 49.88M | 44.81M | 35.81M |
|
|
|||||
| Total Current Liabilities | 44.91M | 51.84M | 49.88M | 44.81M | 35.81M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.00M | 1.00M | -- | -- | -- |
| Capital Leases | 724.90K | 767.00K | 786.70K | -- | 21.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.77M | 7.51M | 7.24M | 6.98M | 6.71M |
| Total Liabilities | 53.41M | 60.12M | 57.91M | 51.78M | 42.55M |
|
|
|||||
| Common Stock & APIC | 306.35M | 295.90M | 282.71M | 276.55M | 271.45M |
| Retained Earnings | -238.80M | -230.84M | -222.06M | -211.14M | -201.37M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 67.55M | 65.06M | 60.66M | 65.41M | 70.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.55M | 65.06M | 60.66M | 65.41M | 70.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 9.98M | 2.50M | 2.92M | 3.51M | 4.02M |
| Total Equity | 77.53M | 67.56M | 63.58M | 68.92M | 74.10M |
|
|
|||||